Barclays’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.3M | Sell |
959,969
-393,218
| -29% | -$31.6M | 0.02% | 567 |
|
|
2026
Q1 | $113M | Sell |
1,353,187
-1,437,103
| -52% | -$108M | 0.03% | 452 |
|
|
2025
Q4 | $187M | Buy |
2,790,290
+847,620
| +44% | +$54.8M | 0.04% | 299 |
|
|
2025
Q3 | $131M | Sell |
1,942,670
-107,983
| -5% | -$7.83M | 0.03% | 406 |
|
|
2025
Q2 | $153M | Buy |
2,050,653
+481,664
| +31% | +$32.1M | 0.04% | 346 |
|
|
2025
Q1 | $98.7M | Sell |
1,568,989
-262,664
| -14% | -$16.2M | 0.03% | 424 |
|
|
2024
Q4 | $104M | Sell |
1,831,653
-270,108
| -13% | -$16M | 0.03% | 395 |
|
|
2024
Q3 | $124M | Sell |
2,101,761
-1,275,986
| -38% | -$69.7M | 0.03% | 368 |
|
|
2024
Q2 | $182M | Buy |
3,377,747
+840,991
| +33% | +$46.3M | 0.06% | 250 |
|
|
2024
Q1 | $146M | Sell |
2,536,756
-567,896
| -18% | -$29.3M | 0.05% | 294 |
|
|
2023
Q4 | $149M | Buy |
3,104,652
+474,225
| +18% | +$22.6M | 0.05% | 301 |
|
|
2023
Q3 | $135M | Buy |
2,630,427
+254,726
| +11% | +$13.5M | 0.08% | 237 |
|
|
2023
Q2 | $136M | Buy |
2,375,701
+1,000,400
| +73% | +$58.4M | 0.09% | 207 |
|
|
2023
Q1 | $82.9M | Buy |
1,375,301
+158,939
| +13% | +$9.71M | 0.04% | 300 |
|
|
2022
Q4 | $71.5M | Buy |
1,216,362
+308,622
| +34% | +$19.5M | 0.03% | 352 |
|
|
2022
Q3 | $51.9M | Buy |
907,740
+338,091
| +59% | +$19.7M | 0.06% | 304 |
|
|
2022
Q2 | $30.8M | Sell |
569,649
-172,788
| -23% | -$10M | 0.02% | 547 |
|
|
2022
Q1 | $42.7M | Sell |
742,437
-861,754
| -54% | -$44M | 0.03% | 462 |
|
|
2021
Q4 | $75.8M | Buy |
1,604,191
+186,899
| +13% | +$8.51M | 0.03% | 431 |
|
|
2021
Q3 | $59.6M | Buy |
1,417,292
+166,481
| +13% | +$7.2M | 0.03% | 456 |
|
|
2021
Q2 | $55.5M | Buy |
1,250,811
+249,595
| +25% | +$11.5M | 0.03% | 475 |
|
|
2021
Q1 | $46.7M | Buy |
1,001,216
+101,077
| +11% | +$4.47M | 0.03% | 474 |
|
|
2020
Q4 | $34.9M | Sell |
900,139
-824,091
| -48% | -$29.5M | 0.02% | 572 |
|
|
2020
Q3 | $49.7M | Buy |
1,724,230
+1,177,270
| +215% | +$33.1M | 0.03% | 399 |
|
|
2020
Q2 | $14.7M | Sell |
546,960
-861,893
| -61% | -$22.4M | 0.01% | 782 |
|
|
2020
Q1 | $33.1M | Sell |
1,408,853
-2,127,678
| -60% | -$58.5M | 0.03% | 447 |
|
|
2019
Q4 | $105M | Buy |
3,536,531
+1,030,341
| +41% | +$27.3M | 0.06% | 264 |
|
|
2019
Q3 | $70.2M | Sell |
2,506,190
-1,364,110
| -35% | -$39.4M | 0.04% | 344 |
|
|
2019
Q2 | $114M | Buy |
+3,870,300
| New | +$104M | 0.07% | 226 |
|
Other funds holding CTVA
Barclays's CTVA Position: Q2 2026 in Review
Barclays reduced its Corteva (CTVA) stake by 29% in Q2 2026, selling an estimated $31.6M and leaving 959,969 shares worth $81.3M. The position accounts for 0.02% of the portfolio, ranked #567.
Barclays first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $187M in Q4 2025. 1,496 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.
- Barclays held 959,969 shares of Corteva worth $81.3M as of Q2 2026.
- Barclays sold 393,218 Corteva shares in Q2 2026, an estimated $31.6M.
- Corteva made up 0.02% of Barclays's portfolio in Q2 2026, its #567 holding.
- Barclays first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
- Barclays's Corteva position peaked at $187M in Q4 2025.
- 1,496 funds tracked by Wall St. Rank held Corteva as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.